Skip to main content
Search
Search
Anywhere
Quick Search anywhere
Enter words / phrases / DOI / ISBN / keywords / authors / etc
Search
Advanced Search
Login
Skip main navigation
Open Drawer Menu
Close Drawer Menu
Home
Journal of Comparative Effectiveness Research
Journal of Patient Centricity
The Evidence Base
Skip slideshow
Journal of Comparative Effectiveness Research
ISSN (print): 2042-6305 • ISSN (online): 2042-6313
Impact Factor: 2.8 (2025) • CiteScore: 4.2 (2025) • Open Access
Read more
Journal of Patient Centricity
ISSN (online): 2978-8579
In partnership with the PCSIG • Open Access
Read more
The Evidence Base
Latest news, opinion and insight into hot topics including RWE, HEOR, HTA and market access
Read more
Latest
Considerations for understanding systematic reviews and network meta-analyses in neurological applications: a review and critique in chronic migraine
Jessica Ailani
,
Christopher D Saffore
,
Ifeanyi Ubamadu
,
Stefano Perni
,
Elizabeth Chertavian
,
Eric B Collins
, and
Si-Tien Wang
Journal of Comparative Effectiveness Research
22 Sep 2026
Indirect treatment comparison of odevixibat and maralixibat for the treatment of cholestatic pruritus in patients with Alagille syndrome
Emmanuelle Kaltenbach
,
Alice Guiraud-Diawara
,
Jérémie Schwarzbard
, and
Cécile Artaud
Journal of Comparative Effectiveness Research
18 Sep 2026
EU HTA update: Medical device JCAs move forward as fourth medicinal-product assessment is discontinued
The Evidence Base
23 Sep 2026
EMA outlines approach to single pivotal trials for marketing authorization
The Evidence Base
23 Sep 2026
Journal of Comparative Effectiveness Research
Open access, peer-reviewed journal offering rapid publication for all aspects of HEOR and related areas
Read More
FROM THE EVIDENCE BASE
23 Sep 2026
EMA outlines approach to single pivotal trials for marketing authorization
22 Sep 2026
US health agency launches SPECTRA autism research program using biological and real-world data
18 Sep 2026
DIA’s 2026 Real-World Evidence Conference: Moving RWE from acceptance to scale
23 Sep 2026
EU HTA update: Medical device JCAs move forward as fourth medicinal-product assessment is discontinued
22 Sep 2026
New EU HTA templates formalize patient, carer and clinician input into JCAs, but transparency gaps remain
16 Sep 2026
Hot off the press: Our pick of articles within HTA and RWE published in August 2026
21 Sep 2026
A Health Economist ventures into the world of investing: Two worlds, two languages
15 Sep 2026
ISPOR Healthcare Investment Summit 2026: Can HEOR bridge the divide between evidence and investment?
9 Sep 2026
Looking ahead to ISPOR Europe 2026: HEOR heads to Vienna
The Evidence Base
Online hub providing the latest news, opinion and insights into HEOR, RWE, HTA and more
Read More
FROM THE EVIDENCE BASE
23 Sep 2026
EU HTA update: Medical device JCAs move forward as fourth medicinal-product assessment is discontinued
23 Sep 2026
EMA outlines approach to single pivotal trials for marketing authorization
22 Sep 2026
New EU HTA templates formalize patient, carer and clinician input into JCAs, but transparency gaps remain
22 Sep 2026
US health agency launches SPECTRA autism research program using biological and real-world data
.png)
.png)
